Cytodyn Inc (CYDY)

[Rockleo]

BioInvestor 4.. Most welcome..

Dr. BP.. Can view the labs .. Perhaps seeing 2/3rds following the Montefiore Study trend.. and rightly determine the patient’s Rx arm.... in the study.

The Sponser .. Dr.NP.. Is privy to the same Lab data..perhaps make the same assumption as Dr.BP.. but in addition..Have the Clinical profiles of the patient’s .. To confirm if good or great results are being translated into clinical improvements..in the patients..

Of course .. these are assumptions... and must be borne out at the unblinding of the Study..That in fact the 2/3rds great results were of the Leronlimab injected patient’s..and the 1/3rd other patients were following the trend seen .. in the rest of the US Corona Patient’s..